search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


Optimising management of viral infections


Over the last three decades, several viral infections have been shown to occur in immunocompromised hosts. A viral load test can optimise the treatment and prevention of infections. Certest Biotec’s new PCR viral load assays can enact this optimisation.


V


iral load tests have proven to be of great clinical utility in the management of many viruses.


Viral quantification and monitoring have introduced several principles of viral disease management. Viral load has been used to predict diseases, guide preventive therapy, assess the efficacy of antiviral treatment, guide the duration of treatment and to indicate the risk of clinical relapse or antiviral drug resistance.


Nucleic acid amplification testing is one of the most commonly performed tests in clinical virology laboratories; however, there remain important limitations that require further optimisation, including the interassay


variability in viral load reporting, which has limited the generation of standardised viral load thresholds for clinical indications. The recent introduction of an international reference standard should advance the major goal of uniform viral load reporting and interpretation. However, it has also become apparent that other aspects of nucleic acid testing should be standardised. Following WHO guidelines and with the main objective of uniform reporting and interpretation of viral load, CerTest Biotec have developed several real-time PCR assays with a wide dynamic range of quantification, with high sensitivity, specificity and reproducibility and with improved


operational characteristics with respect to other previously available assays. These kits detect, quantify and monitor the viral load of microorganisms for various infections by real-time PCR where reverse transcription and subsequent amplification of the specific target sequence: using specific oligonucleotides and a fluorescently- labelled probe and a quantified synthetic positive control. All reagents and controls needed to perform PCR and quantification are in a stabilised, laboratory-ready format, making operational handling simple and easy to standardise. ●


www.certest.es


Practical Patient Care / www.practical-patient-care.com


23


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73